China IVD Market – Key Facts Covered
• By 2018 Chinese IVD market with Billion US$ is expected to be twice more than from its current market size in 2013
• Immunoassay controls more than 50% market share in China IVD market in 2013
• It is estimated that clinical chemistry market in China will be little less than US$ 1 Billion by 2018
• China Hematology market is expected to cross US$ 150 Million mark by 2018
• China Microbiology market had crossed the figure of US$ 100 Million in 2011
• It is forecasted that China molecular testing market will be more than US$ 500 Million by 2018
China is gradually becoming a competitive force and evolving into the world’s fastest growing market for In Vitro Diagnostics (IVD) products. By 2018 Chinese IVD market with Billion US$ is expected to be twice more than from its current market size in 2013. Immunoassay has the highest market share compared to all other segments of In Vitro Diagnostics. Clinical Chemistry is in the 2nd position, but its market share is declining year on year, however its market is growing year on year. Molecular Diagnostics holds the 3rd position and its market share is also rising year on year. Roche holds the highest market share in China In Vitro Diagnostics market.
This is 3rd edition report on In Vitro Diagnostics sector by Renub Research. Report titled “China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis” provides a comprehensive assessment of the fast–evolving, high–growth IVD Market in China. This 77 page report with 34 Figures studies the China IVD market from 4 view points:
1) Market and Forecast
2) Segment Wise Market & Forecast
3) Development Environment & Regulatory Status in China IVD market
4) Company Wise IVD Sales & Forecast
China IVD Market – Application Segment Analysis (2007 – 2018)
• Clinical Chemistry Market
• Immunoassay Market
• Hematology Market
• Coagulation Market
• Microbiology Market
• Molecular Testing Market
• Self Monitoring of Blood Glucose (SMBG) Market
• Point of Care Testing (POCT) Market
China IVD – Company Wise Sales Analysis (2010 – 2018)
• Roche Diagnostic
• Sysmex Corporation
• Mindray Medical International Limited
• Shanghai Kehua Bio–Engineering Co. Ltd.
Profiles of Private Clinical Labs and Diagnostic Services Companies in China
• Zhejiang Di’an Diagnostics Technology Co., Ltd
• ADICON Clinical Laboratories
• Guangzhou Kingmed Diagnostics Center Co. Ltd.
• Kindstar Global (Privately held)
• BGI–Shenzhen (Privately held)
• OriGene Technologies (Privately held)
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
Click here to view the report Details: http://www.renub.com/report/china-in-vitro-diagnostics-ivd-market-forecast-companies-analysis-154
For more information visit: http://www.renub.com/
Sales & Marketing Div
Phone: +1-678-302-0700 (USA), +91-120-421-9822, +91-120-254-5750 (India)
2 Yaers Ago, Wednesday, May 27, 2015, 01:14:59